Text Size
81 studies found for:    "celiac disease"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Safety Study of Nexvax2 in Subjects With Coeliac Disease
Conditions: Coeliac Disease;   Celiac Disease
Interventions: Biological: 9 micrograms Nexvax2;   Biological: 30 micrograms Nexvax2;   Biological: 90 micrograms Nexvax2;   Biological: 60 micrograms Nexvax2;   Biological: Up to 900 micrograms Nexvax2;   Other: Placebo
2 Recruiting Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Condition: Celiac Disease
Intervention:
3 Not yet recruiting Oral AGY for Celiac Disease
Condition: Celiac Disease
Intervention: Other: AGY
4 Completed Safety and Efficacy of ALV003 for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Biological: ALV003;   Biological: ALV003 placebo
5 Completed Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Biological: ALV003;   Biological: ALV003 placebo
6 Active, not recruiting A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide Acetate 0.5 mg;   Drug: Larazotide Acetate 1 mg;   Drug: Larazotide Acetate 2 mg;   Drug: placebo
7 Completed Treatment of Mild Enteropathy Celiac Disease
Condition: Celiac Disease
Intervention: Dietary Supplement: Gluten-free diet
8 Recruiting Impact of the Diagnosis of Celiac Disease
Condition: Celiac Disease
Intervention:
9 Unknown † Celiac Disease Database
Condition: Celiac Disease
Intervention:
10 Completed Treatment of Screen-detected Celiac Disease
Condition: Celiac Disease
Intervention: Dietary Supplement: Gluten-free diet
11 Completed Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Disease
Condition: Celiac Disease
Intervention: Drug: Simvastatin
12 Unknown † Study of Enzyme Supplements to Treat Celiac Disease
Conditions: Celiac Disease;   Dermatitis Herpetiformis
Interventions: Drug: STAN1;   Drug: Placebo enzyme;   Drug: STAN1+gluten
13 Active, not recruiting Celiac Disease Prevention
Condition: Celiac Disease
Intervention: Other: Optimal gluten introduction
14 Completed Clinical Trial on the Effects of Bifidobacterium Infantis in Active Celiac Disease
Condition: Celiac Disease
Intervention: Dietary Supplement: Probiotic
15 Terminated Response to Hepatitis B Vaccine in Celiac Disease Patients
Condition: Celiac Disease
Intervention: Biological: hepatitis B vaccine (EngerixB)
16 Completed A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease
Condition: Celiac Disease
Intervention: Drug: 4 dose levels of ALV003
17 Completed Phase IIb Study to Study the Efficacy of AT1001 to Treat Celiac Disease
Condition: Celiac Disease
Interventions: Drug: AT-1001;   Drug: placebo
18 Completed Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide acetate (AT1001);   Drug: Placebo
19 Completed Effect of Addition of Short Course of Prednisolone to Gluten Free Diet in Naive Celiac Disease Patients
Condition: Celiac Disease
Interventions: Drug: Prednisolone and Gluten free diet;   Behavioral: Gluten free diet
20 Completed Saliva Composition and Oral Hygiene in Children With Celiac Disease Before and After the Change in Diet
Condition: Celiac Disease
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years